Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArmadale Capital Regulatory News (ACP)

  • There is currently no data for ACP

Update Regarding Company Led Subscription

16 Jul 2024 08:00

RNS Number : 5603W
Armadale Capital PLC
16 July 2024
 

 

16 July 2024

Armadale Capital Plc

('Armadale' the 'Company' or the 'Group')

Update re Subscription

Armadale announced on 24 April 2024 that it had conditionally raised £650,000 through the issue by the Company of new ordinary shares in the Company ("Ordinary Shares") at an issue price of 0.7 pence per new Ordinary Share ("Subscription Shares") through a Company led direct subscription with new and existing investors in the UK and Australia (the "Subscription").

As set out in the Company's audited annual results for the year ended 31 December 2023 published on 28 June 2024, funds pursuant to the Subscription totalling £150,000 were still to be received from certain investors as at that date. As at the date of this announcement, this amount remains outstanding with the Company is continuing to pursue all practicable measures to collect the outstanding funds from the investors. However, the Company has decided to finalise the Subscription through the issue of new Ordinary Shares in respect of gross funds received to date, totalling £500,000.

Accordingly, application will be made for 71,428,561 Subscription Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will occur on or around 19 July 2024.

Following Admission, the Company's issued ordinary share capital will consist of 658,958,456 ordinary shares with one voting right each ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company will be 658,958,456. With effect from Admission, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

In addition, and as set out in in the announcement dated 24 April 2024 attached to each Subscription Share is a warrant, exercisable within 36 months at a price of 1.2p per new Ordinary Share (the "Warrants") with each Warrant entitling each Warrant holder the right to subscribe for a further Ordinary Share in Armadale.

Following the issue of the Warrants pursuant to the Subscription the Company will have warrants outstanding over 71,428,561 Ordinary Shares.

In addition, and as previously announced on 24 April 2024, Matt Bull, Executive Director of the Company agreed to participate in the Subscription. In light of the quantum of the Subscription now being lower than the Company had originally anticipated, following Admission, Mr Bull's resultant holding in the Company will now be as follows:

 

 

 

Name

 

Current number of Ordinary Shares held

 

% of existing number of Ordinary Shares

 

Number of Placing Shares subscribed for

 

Number of Ordinary Shares held post-Admission

 

% of issued share capital as enlarged by the Placing

Matt Bull

47,783,284

8.1%

14,285,714

62,068,998

9.4%

 

The board would like to reiterate to shareholders the statements made in the Company's audited results for the year ended 31 December 2023, that additional funds will be required within the next twelve months as a result the Company is considering various the strategic options available to it to effectively advance the Company's projects.

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

Enquiries:

Armadale Capital Plc

Matt Bull, Director

Tim Jones, Company Secretary

+44 (0) 20 7236 1177

 

Nomad and Broker: Cavendish Capital Markets Limited

Neil McDonald / Seamus Fricker

 

+44 (0) 20 7220 0500

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUNSNRSNUBARR
Date   Source Headline
13th Nov 20247:00 amRNSCancellation - Armadale Capital plc
6th Nov 20246:00 pmRNSArmadale Capital
4th Nov 20249:15 amRNSResult of General Meeting
16th Oct 20246:00 pmRNSPosting of Circular and Notice of GM
14th Oct 20249:00 amRNSProposed Cancellation of Admission, Notice of GM
3rd Oct 20248:30 amRNSResult of AGM
1st Oct 20247:00 amRNSInterim Results
9th Sep 20249:37 amRNSCanyon Silver Project Update
25th Jul 202410:31 amRNSDirector/PDMR Shareholding
16th Jul 20248:00 amRNSUpdate Regarding Company Led Subscription
28th Jun 20245:07 pmRNSFinal Results and Notice of AGM
20th Jun 202410:00 amRNSInvestor Presentation
19th Jun 20247:00 amRNSBlock listing Interim Review
18th Jun 202410:30 amRNSCanyon Silver Results and Update on Subscription
22nd May 20242:00 pmRNSMahenge Graphite Update
15th May 20248:05 amRNSUpdate re: Admission of Subscription Shares
14th May 20247:00 amRNSRe-opening of the Canyon Silver Mine Shaft
2nd May 20249:30 amRNSUpdate on Canyon Silver Asset
24th Apr 20248:30 amRNSProposed Investment, Subscription & Board Changes
27th Feb 20242:45 pmRNSMahenge Project Update
19th Dec 202311:15 amRNSBlock listing Interim Review
29th Sep 20237:00 amRNSHalf-year Report
20th Jun 202310:38 amRNSResult of AGM
19th Jun 20237:00 amRNSBlock listing Interim Review
12th May 20237:00 amRNSFinal Results and Notice of AGM
13th Feb 20239:00 amRNSMahenge Project Update
19th Dec 20227:00 amRNSBlock listing Interim Review
29th Sep 20227:00 amRNSHalf-year Report
20th Jun 202210:45 amRNSResult of AGM
17th Jun 20223:30 pmRNSBlock listing Interim Review
23rd May 20227:00 amRNSFinal Results and Notice of AGM
3rd May 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Apr 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
17th Mar 20223:20 pmRNSHolding(s) in Company
11th Mar 20222:45 pmRNSDirector/PDMR Shareholding and TVR
8th Feb 20228:15 amRNSAdvancing Mining Lease and Expanded Footprint
17th Dec 20217:00 amRNSBlock listing Interim Review
15th Dec 20219:30 amRNSManagement Team Enhanced With Key Appointment
1st Dec 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Nov 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Oct 20217:00 amRNSIssue of equity under block admission arrangements
29th Sep 20217:00 amRNSHalf-year Report
3rd Sep 20219:00 amRNSMahenge Mining Licence Granted
31st Aug 20217:00 amRNSNotification of Changes in Major Holdings
6th Aug 20211:25 pmRNSConversion of Loan Notes and Director Shareholding
28th Jun 202112:40 pmRNSBlock Admission & TVR
28th Jun 202112:18 pmRNSAGM Statement
17th Jun 20217:00 amRNSBlock listing Interim Review
28th May 20213:45 pmRNSSubscription and Investment Portfolio Update
28th May 20213:18 pmRNSFinal Results And Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.